Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women

ABSTRACT Human papillomavirus (HPV) is an etiologic agent for both oropharyngeal and cervical cancers, yet little is known about the interrelationship between oral and cervical HPV infections. Therefore, we compared the prevalences and type distributions of oral and cervical HPV infections and evaluated infection concordance in a cross-sectional study within the Women's Interagency HIV Study cohort. Oral rinse and cervical-vaginal lavage samples were concurrently collected from a convenience sample of 172 human immunodeficiency virus (HIV)-positive and 86 HIV-negative women. HPV genomic DNA was detected by PGMY09/11 L1 consensus primer PCR and type specified by reverse line blot hybridization for 37 HPV types and β-globin. Only 26 of the 35 HPV types found to infect the cervix were also found within the oral cavity, and the type distribution for oral HPV infections appeared distinct from that for cervical infections (P < 0.001). Oral HPV infections were less common than cervical infections for both HIV-positive (25.2% versus 76.9%, P < 0.001) and HIV-negative (9.0% versus 44.9%, P < 0.001) women. Oral HPV infections were more common among women with a cervical HPV infection than those without a cervical HPV infection (25.5% versus 7.9%, P = 0.002). The majority of women (207; 93.7%) did not have simultaneous oral and cervical infections by the same HPV type; however, the number of women who did (14; 6.3%) was significantly greater than would be expected by chance (P = 0.0002). Therefore, the oral and cervical reservoirs for HPV infection are likely not entirely independent of one another.

[1]  G. Scambia,et al.  Concurrent HPV infection in oral and genital mucosa. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  E. Sugar,et al.  Analysis of the Effect of DNA Purification on Detection of Human Papillomavirus in Oral Rinse Samples by PCR , 2005, Journal of Clinical Microbiology.

[3]  M. Hagensee,et al.  The Impact of Highly Active Antiretroviral Therapy and Immunodeficiency on Human Papillomavirus Infection of the Oral Cavity of Human Immunodeficiency Virus–Seropositive Adults , 2005, Sexually transmitted diseases.

[4]  J. Papp,et al.  Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. , 2005, American journal of epidemiology.

[5]  J. Dillner,et al.  Chlamydia trachomatis infection and persistence of human papillomavirus , 2005, International journal of cancer.

[6]  R. DeSalle,et al.  The carcinogenicity of human papillomavirus types reflects viral evolution. , 2005, Virology.

[7]  S. Wacholder,et al.  A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. , 2005, The Journal of infectious diseases.

[8]  K. Anastos,et al.  Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. , 2005, Journal of the National Cancer Institute.

[9]  B. Hansson,et al.  Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden , 2005, Acta oto-laryngologica.

[10]  A. Bladström,et al.  Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden , 2005, Acta oto-laryngologica.

[11]  M. Gillison,et al.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.

[12]  Mardge H. Cohen,et al.  Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. , 2004, The Journal of infectious diseases.

[13]  S. de Sanjosé,et al.  Concordance of Prevalence of Human Papillomavirus DNA in Anogenital and Oral Infections in a High-Risk Population , 2004, Journal of Clinical Microbiology.

[14]  K. Shah,et al.  Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. , 2004, The Journal of infectious diseases.

[15]  L. Turek,et al.  Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. , 2003, Journal of the National Cancer Institute.

[16]  N. Muñoz,et al.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. , 2003, Journal of the National Cancer Institute. Monographs.

[17]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[18]  S. Franceschi,et al.  Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. , 2002, Journal of the National Cancer Institute.

[19]  A. Giuliano,et al.  Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States) , 2002, Cancer Causes & Control.

[20]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[21]  V. Moreno,et al.  Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study , 2002, The Lancet.

[22]  P. Fuchs,et al.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.

[23]  C. Peyton,et al.  Determinants of genital human papillomavirus detection in a US population. , 2001, The Journal of infectious diseases.

[24]  J. Goedert,et al.  Association of cancer with AIDS-related immunosuppression in adults. , 2001, JAMA.

[25]  P. Porter,et al.  Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  L. Brinton,et al.  Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[28]  S. Schwartz,et al.  Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.

[29]  C. Peyton,et al.  Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method , 1998, Journal of Clinical Microbiology.

[30]  Joseph Feldman,et al.  The Women's Interagency HIV Study , 1998 .

[31]  F. Coutlée,et al.  Risk Factors for Oral Human Papillomavirus in Adults Infected and Not Infected With Human Immunodeficiency Virus , 1997, Sexually transmitted diseases.

[32]  E. de Villiers,et al.  Novel HPV types present in oral papillomatous lesions from patients with HIV infection , 1996, International journal of cancer.

[33]  C. Jones,et al.  Cervical cancer: is herpes simplex virus type II a cofactor? , 1995, Clinical microbiology reviews.

[34]  S. Syrjänen,et al.  Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[35]  E. de Villiers,et al.  Unusual HPV types in oral warts in association with HIV infection. , 1988, Journal of oral pathology.